MarketBeat on MSN2 小时
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
ORIC Pharmaceuticals (NASDAQ: ORIC) is a small-cap pharma stock. It aims to make a difference with its potentially ...
Hope on the Horizon: Nephrologists Emphasize Need for Innovative C3G Treatments as Novartis ...
Findings from Spherix Global Insights show that practitioners consider nearly half of their C3G patients to be potential candidates for Fabhalta or Empaveli, if approved.EXTON, PA, Nov. 15, 2024 ...